Literature DB >> 20709392

Alpha-lipoic acid inhibits thrombin-induced fetal membrane weakening in vitro.

R M Moore1, F Schatz, D Kumar, B M Mercer, A Abdelrahim, N Rangaswamy, C Bartel, J M Mansour, C J Lockwood, J J Moore.   

Abstract

Cytokine-mediated inflammation and abruption-induced thrombin generation are separately implicated in matrix metalloproteinase (MMP)-mediated weakening of fetal membranes (FM) leading to preterm premature rupture of the fetal membranes (PPROM). At term, FM of both labored vaginal and unlabored Cesarean deliveries exhibit a weak zone overlying the cervix exhibiting ECM remodeling characterized by increased MMP9 protein and activity. We have reproduced these biochemical changes as well as FM weakening in vitro using tumor necrosis factor-alpha (TNF) and interleukin (IL)-1β, inflammatory cytokines implicated in PPROM. Additionally, we have reported that the antioxidant and NFκB inhibitor alpha-lipoic Acid (LA) blocks these TNF-induced effects. We now present the first direct evidence that thrombin also can induce FM weakening in vitro, and LA treatment inhibits this thrombin-induced-weakening. Full thickness FM fragments from unlabored Cesarean deliveries were incubated with increasing doses of thrombin (0-100 u/ml) for 48 h. Fragments were then strength tested (breaking force and work to rupture) using our published methodology. MMP3 and 9 levels in tissue extracts were determined by Western blot and densitometry. To determine the effect of LA, FM fragments were incubated with control medium or 10 u/ml thrombin, with or without 0.25 mM LA. Strength testing and MMP induction were determined. Thrombin induced a dose-dependent decrease in FM strength (42% baseline rupture force and 45% work to rupture) coupled with a dose-dependent increase in MMP3 and 9 expression (all p < 0.001). Treatment of FM with 0.25 mM LA completely inhibited thrombin-induced FM weakening and MMP expression (all p < 0.001). Thrombin treatment of cultured FM induces mechanical weakening and increased MMP3 and 9. Treatment of FM with LA inhibits these thrombin-induced effects. We speculate LA may prove clinically useful in prevention of PPROM associated with abruption.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709392      PMCID: PMC2945435          DOI: 10.1016/j.placenta.2010.07.012

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  43 in total

1.  The role of thrombin in preterm parturition.

Authors:  M A Elovitz; J Baron; M Phillippe
Journal:  Am J Obstet Gynecol       Date:  2001-11       Impact factor: 8.661

2.  Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor.

Authors:  Ping Xu; Nadia Alfaidy; John R G Challis
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

Review 3.  Decidual cell-expressed tissue factor maintains hemostasis in human endometrium.

Authors:  C J Lockwood; G Krikun; F Schatz
Journal:  Ann N Y Acad Sci       Date:  2001-09       Impact factor: 5.691

4.  Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes.

Authors:  T Rosen; E Kuczynski; L M O'Neill; E F Funai; C J Lockwood
Journal:  J Matern Fetal Med       Date:  2001-10

5.  Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes.

Authors:  Roberto Romero; Tinnakorn Chaiworapongsa; Jimmy Espinoza; Ricardo Gomez; Bo Hyun Yoon; Sam Edwin; Moshe Mazor; Eli Maymon; Stanley Berry
Journal:  Am J Obstet Gynecol       Date:  2002-11       Impact factor: 8.661

6.  Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes.

Authors:  T Rosen; F Schatz; E Kuczynski; H Lam; A B Koo; C J Lockwood
Journal:  J Matern Fetal Neonatal Med       Date:  2002-01

7.  Activation of coagulation system in preterm labor and preterm premature rupture of membranes.

Authors:  T Chaiworapongsa; J Espinoza; J Yoshimatsu; Y M Kim; E Bujold; S Edwin; B H Yoon; R Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2002-06

Review 8.  The role of matrix degrading enzymes and apoptosis in rupture of membranes.

Authors:  Ramkumar Menon; Stephen J Fortunato
Journal:  J Soc Gynecol Investig       Date:  2004-10

9.  Protease activated receptor-1 is down regulated by levonorgestrel in endometrial stromal cells.

Authors:  S Hague; M K Oehler; I Z MacKenzie; R Bicknell; M C P Rees
Journal:  Angiogenesis       Date:  2002       Impact factor: 9.596

Review 10.  Preterm premature rupture of the membranes.

Authors:  Brian M Mercer
Journal:  Obstet Gynecol       Date:  2003-01       Impact factor: 7.661

View more
  10 in total

Review 1.  Extracellular matrix dynamics and fetal membrane rupture.

Authors:  Jerome F Strauss
Journal:  Reprod Sci       Date:  2012-01-19       Impact factor: 3.060

2.  Effect of thrombin on human amnion mesenchymal cells, mouse fetal membranes, and preterm birth.

Authors:  Haruta Mogami; Patrick W Keller; Haolin Shi; R Ann Word
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

3.  In-vivo stretch of term human fetal membranes.

Authors:  E M Joyce; P Diaz; S Tamarkin; R Moore; A Strohl; B Stetzer; D Kumar; M S Sacks; J J Moore
Journal:  Placenta       Date:  2015-12-20       Impact factor: 3.481

Review 4.  Preterm prelabor rupture of the membranes: A disease of the fetal membranes.

Authors:  Ramkumar Menon; Lauren S Richardson
Journal:  Semin Perinatol       Date:  2017-08-12       Impact factor: 3.300

Review 5.  Synergy and interactions among biological pathways leading to preterm premature rupture of membranes.

Authors:  Sophia M R Lannon; Jeroen P Vanderhoeven; David A Eschenbach; Michael G Gravett; Kristina M Adams Waldorf
Journal:  Reprod Sci       Date:  2014-05-19       Impact factor: 3.060

6.  The effects of thrombin and cytokines upon the biomechanics and remodeling of isolated amnion membrane, in vitro.

Authors:  D Kumar; F Schatz; R M Moore; B M Mercer; N Rangaswamy; J M Mansour; C J Lockwood; J J Moore
Journal:  Placenta       Date:  2011-03       Impact factor: 3.481

Review 7.  Human fetal membranes at term: Dead tissue or signalers of parturition?

Authors:  Ramkumar Menon
Journal:  Placenta       Date:  2016-05-29       Impact factor: 3.481

8.  Progesterone receptor membrane component 1 as the mediator of the inhibitory effect of progestins on cytokine-induced matrix metalloproteinase 9 activity in vitro.

Authors:  Terrence K Allen; Liping Feng; Chad A Grotegut; Amy P Murtha
Journal:  Reprod Sci       Date:  2013-06-27       Impact factor: 3.060

Review 9.  Inositol and antioxidant supplementation: Safety and efficacy in pregnancy.

Authors:  Gloria Formoso; Maria P A Baldassarre; Federica Ginestra; Maria Assunta Carlucci; Ines Bucci; Agostino Consoli
Journal:  Diabetes Metab Res Rev       Date:  2019-04-10       Impact factor: 4.876

10.  Single Nucleotide Polymorphisms from CSF2, FLT1, TFPI and TLR9 Genes Are Associated with Prelabor Rupture of Membranes.

Authors:  Wioletta Izabela Wujcicka; Marian Kacerovsky; Michał Krekora; Piotr Kaczmarek; Mariusz Grzesiak
Journal:  Genes (Basel)       Date:  2021-10-28       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.